The Manila Times

ARKO Corp. Appoints Galagher Jeff as Chief Financial Officer

Jeff is a Seasoned Financial Leader with Significant Industry Experience ...
The Manila Times

Altimmune Announces CEO Transition and Succession Plan

(Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...